Evidence map›Paper›PMID 17682060›Full record

ArticleMolecular and cellular biology2007

Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway.

Imad Shams, Edyta Rohmann, Veraragavan P Eswarakumar, Erin D Lew, Satoru Yuzawa, Bernd Wollnik, Joseph Schlessinger, Irit Lax

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. The molecular genetics of human appendicular skeleton.Molecular genetics and genomics : MGG · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Cell signaling regulation in salivary gland development.Cellular and molecular life sciences : CMLS · 2021
    Review
  11. Review
  12. Review
  13. Review
  14. A requirement for Fgfr2 in middle ear development.Genesis (New York, N.Y. : 2000) · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Lacrimal gland development: From signaling interactions to regenerative medicine.Developmental dynamics : an official publication of the American Association of Anatomists · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Imad ShamsDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Edyta Rohmann
Veraragavan P Eswarakumar
Erin D Lew
Satoru Yuzawa
Bernd Wollnik
Joseph Schlessinger
Irit Lax
Yale University · USUniversity of Cologne · DE

Funding

Research Core: Biochemistry and histology/histomorphometryP50AR054086 · NIAMS · YALE UNIVERSITY · PI DEMAY, MARIE · 2006 to 2010
$8.5M
FGF RECEPTOR SIGNALING IN BONE DEVELOPMENTR01AR051886 · NIAMS · YALE UNIVERSITY · PI SCHLESSINGER, JOSEPH · 2005 to 2009
$1.7M
NIAMS NIH HHS AR05141448NIAMS NIH HHS AR051886NIAMS NIH HHS P50 AR054086NIAMS NIH HHS R01 AR051886
6 · The paper itself

Abstract

Lacrimo-auriculo-dento-digital (LADD) syndrome is characterized by abnormalities in lacrimal and salivary glands, in teeth, and in the distal limbs. Genetic studies have implicated heterozygous mutations in fibroblast growth factor 10 (FGF10) and in FGF receptor 2 (FGFR2) in LADD syndrome. However, it is not clear whether LADD syndrome mutations (LADD mutations) are gain- or loss-of-function mutations. In order to reveal the molecular mechanism underlying LADD syndrome, we have compared the biological properties of FGF10 LADD and FGFR2 LADD mutants to the activities of their normal counterparts. These experiments show that the biological activities of three different FGF10 LADD mutants are severely impaired by different mechanisms. Moreover, haploinsufficiency caused by defective FGF10 mutants leads to LADD syndrome. We also demonstrate that the tyrosine kinase activities of FGFR2 LADD mutants expressed in transfected cells are strongly compromised. Since tyrosine kinase activity is stimulated by ligand-induced receptor dimerization, FGFR2 LADD mutants may also exert a dominant inhibitory effect on signaling via wild-type FGFR2 expressed in the same cell. These experiments underscore the importance of signal strength in mediating biological responses and that relatively small changes in receptor signaling may influence the outcome of developmental processes in cells or organs that do not possess redundant signaling pathway.

Indexed as

Abnormalities, MultipleLimb Deformities, CongenitalTooth AbnormalitiesCell LineFibroblast Growth Factor 10HumansLacrimal ApparatusModels, MolecularProtein ConformationReceptor, Fibroblast Growth Factor, Type 2Salivary GlandsSignal TransductionSyndromeFGF10 protein, humanFibroblast Growth Factor 10Receptor, Fibroblast Growth Factor, Type 2

Identifiers

PMID17682060
PMCPMC2099236
OpenAlexW2102543444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.